Spyre Therapeutics Statistics

Total Valuation

SYRE has a market cap or net worth of $1.40 billion. The enterprise value is $986.50 million.

Market Cap	1.40B
Enterprise Value	986.50M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

SYRE has 58.71 million shares outstanding. The number of shares has increased by 845.79% in one year.

Current Share Class	58.71M
Shares Outstanding	58.71M
Shares Change (YoY)	+845.79%
Shares Change (QoQ)	+12.30%
Owned by Insiders (%)	8.79%
Owned by Institutions (%)	76.08%
Float	45.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.15
P/TBV Ratio	8.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.32

Current Ratio	7.32
Quick Ratio	7.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.62% and return on invested capital (ROIC) is -51.98%.

Return on Equity (ROE)	-91.62%
Return on Assets (ROA)	-38.81%
Return on Capital (ROIC)	-51.98%
Revenue Per Employee	n/a
Profits Per Employee	-$7.16M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SYRE has paid $50,000 in taxes.

Income Tax	50,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.49% in the last 52 weeks. The beta is 2.84, so SYRE's price volatility has been higher than the market average.

Beta (5Y)	2.84
52-Week Price Change	+45.49%
50-Day Moving Average	30.27
200-Day Moving Average	31.23
Relative Strength Index (RSI)	36.55
Average Volume (20 Days)	573,912

Short Selling Information

The latest short interest is 8.86 million, so 15.09% of the outstanding shares have been sold short.

Short Interest	8.86M
Short Previous Month	8.04M
Short % of Shares Out	15.09%
Short % of Float	19.36%
Short Ratio (days to cover)	13.13

Income Statement

Revenue	n/a
Gross Profit	-84.05M
Operating Income	-195.07M
Pretax Income	-185.95M
Net Income	-214.90M
EBITDA	-194.51M
EBIT	-195.07M
Earnings Per Share (EPS)	-$5.79

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	414.23M
Total Debt	n/a
Net Cash	414.23M
Net Cash Per Share	$7.06
Equity (Book Value)	327.39M
Book Value Per Share	3.34
Working Capital	363.54M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-151.25M
Capital Expenditures	n/a
Free Cash Flow	-151.25M
FCF Per Share	-$2.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-845.79%
Shareholder Yield	-845.79%
Earnings Yield	-15.34%
FCF Yield	-10.80%

Analyst Forecast

The average price target for SYRE is $51.50, which is 115.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$51.50
Price Target Difference	115.84%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	-18.74%
EPS Growth Forecast (5Y)	-28.52%

Stock Forecasts

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Sep 8, 2023
Split Type	Reverse
Split Ratio	0.04:1

Scores

SYRE has an Altman Z-Score of 3.09 and a Piotroski F-Score of 2.

Altman Z-Score	3.09
Piotroski F-Score	2